{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:54:34Z","timestamp":1790553274489,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","funder":[{"name":"Nestle Skin Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s13555-017-0176-3","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T07:41:45Z","timestamp":1488181305000},"page":"213-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models"],"prefix":"10.1007","volume":"7","author":[{"given":"S\u00e9verine","family":"Thibaut de M\u00e9nonville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Rosignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Roquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Defoin-Platel\/Chaussade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piwnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"issue":"3","key":"176_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","volume":"51","author":"GH Crawford","year":"2004","unstructured":"Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327\u201341 (quiz 42\u201344).","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"176_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","volume":"15","author":"M Steinhoff","year":"2011","unstructured":"Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2\u201311.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"176_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","volume":"15","author":"VD Schwab","year":"2011","unstructured":"Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53\u201362.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"176_CR4","first-page":"694","volume":"11","author":"JQ Rosso Del","year":"2012","unstructured":"Del Rosso JQ, Gallo RL, Kircik L, Thiboutot D, Baldwin HE, Cohen D. Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin. J Drugs Dermatol. 2012;11(6):694\u2013700.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"176_CR5","first-page":"20","volume":"7","author":"AM Two","year":"2014","unstructured":"Two AM, Del Rosso JQ. Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. J Clin Aesthet Dermatol. 2014;7(1):20\u20135.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"12","key":"176_CR6","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","volume":"20","author":"K Yamasaki","year":"2006","unstructured":"Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 2006;20(12):2068\u201380.","journal-title":"FASEB J"},{"issue":"1","key":"176_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jidsymp.2011.2","volume":"15","author":"U Meyer-Hoffert","year":"2011","unstructured":"Meyer-Hoffert U, Schroder JM. Epidermal proteases in the pathogenesis of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):16\u201323.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"176_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","volume":"15","author":"K Yamasaki","year":"2011","unstructured":"Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15(1):12\u20135.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"176_CR9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","volume":"131","author":"K Yamasaki","year":"2011","unstructured":"Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011;131(3):688\u201397.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"176_CR10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975\u201380.","journal-title":"Nat Med"},{"issue":"7","key":"176_CR11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","volume":"192","author":"Y De","year":"2000","unstructured":"De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192(7):1069\u201374.","journal-title":"J Exp Med"},{"issue":"11","key":"176_CR12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","volume":"111","author":"R Koczulla","year":"2003","unstructured":"Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18. J Clin Invest. 2003;111(11):1665\u201372.","journal-title":"J Clin Invest."},{"issue":"6","key":"176_CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/exd.12401","volume":"23","author":"S Salzer","year":"2014","unstructured":"Salzer S, Ruzicka T, Schauber J. Face-to-face with anti-inflammatory therapy for rosacea. Exp Dermatol. 2014;23(6):379\u201381.","journal-title":"Exp Dermatol"},{"issue":"5","key":"176_CR14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/jid.2012.14","volume":"132","author":"KN Kanada","year":"2012","unstructured":"Kanada KN, Nakatsuji T, Gallo RL. Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin. J Invest Dermatol. 2012;132(5):1435\u201342.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"176_CR15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaad.2013.05.019","volume":"69","author":"AB Coda","year":"2013","unstructured":"Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, et al. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013;69(4):570\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"176_CR16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2016.01.023","volume":"74","author":"A Nardo Di","year":"2016","unstructured":"Di Nardo A, Holmes AD, Muto Y, Huang EY, Preston N, Winkelman WJ, et al. Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial. J Am Acad Dermatol. 2016;74(6):1086\u201392.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"176_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/09546634.2014.991672","volume":"26","author":"M Abokwidir","year":"2015","unstructured":"Abokwidir M, Fleischer AB. An emerging treatment: topical ivermectin for papulopustular rosacea. J Dermatolog Treat. 2015;26(4):379\u201380.","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"176_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00011-011-0307-8","volume":"60","author":"S Yan","year":"2011","unstructured":"Yan S, Ci X, Chen N, Chen C, Li X, Chu X, et al. Anti-inflammatory effects of ivermectin in mouse model of allergic asthma. Inflamm Res. 2011;60(6):589\u201396.","journal-title":"Inflamm Res"},{"issue":"3","key":"176_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0092-8674(75)90183-X","volume":"6","author":"JG Rheinwald","year":"1975","unstructured":"Rheinwald JG, Green H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell. 1975;6(3):317\u201330.","journal-title":"Cell"},{"issue":"3","key":"176_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(75)80001-8","volume":"6","author":"JG Rheinwald","year":"1975","unstructured":"Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6(3):331\u201343.","journal-title":"Cell"},{"issue":"4","key":"176_CR21","first-page":"357","volume":"24","author":"M Prunieras","year":"1979","unstructured":"Prunieras M, Regnier M, Schlotterer M. New procedure for culturing human epidermal cells on allogenic or xenogenic skin: preparation of recombined grafts. Ann Chir Plast. 1979;24(4):357\u201362.","journal-title":"Ann Chir Plast"},{"issue":"5","key":"176_CR22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/jid.2009.435","volume":"130","author":"S Morizane","year":"2010","unstructured":"Morizane S, Yamasaki K, Kabigting FD, Gallo RL. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol. 2010;130(5):1297\u2013306.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"176_CR23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00011-008-8007-8","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang X, Song Y, Ci X, An N, Ju Y, Li H, et al. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm Res. 2008;57(11):524\u20139.","journal-title":"Inflamm Res"},{"issue":"5","key":"176_CR24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1189\/jlb.72.5.847","volume":"72","author":"E Hoffmann","year":"2002","unstructured":"Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72(5):847\u201355.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"176_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1440-1711.1999.00858.x","volume":"77","author":"S Mahalingam","year":"1999","unstructured":"Mahalingam S, Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol. 1999;77(6):469\u201375.","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"176_CR26","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5700599","volume":"127","author":"F Niyonsaba","year":"2007","unstructured":"Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007;127(3):594\u2013604.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"176_CR27","first-page":"1380","volume":"13","author":"L Stein Gold","year":"2014","unstructured":"Stein Gold L, Kircik L, Fowler J, Jackson JM, Tan J, Draelos Z, et al. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. J Drugs Dermatol. 2014;13(11):1380\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"176_CR28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jdv.13537","volume":"30","author":"A Taieb","year":"2016","unstructured":"Taieb A, Khemis A, Ruzicka T, Baranska-Rybak W, Berth-Jones J, Schauber J, et al. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study. J Eur Acad Dermatol Venereol. 2016;30(5):829\u201336.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-017-0176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:14:47Z","timestamp":1692702887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-017-0176-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1007\/s13555-017-0176-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}